41,629 Shares in Semler Scientific Inc. $SMLR Purchased by Accuvest Global Advisors

Accuvest Global Advisors bought a new position in Semler Scientific Inc. (NASDAQ:SMLR) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 41,629 shares of the company’s stock, valued at approximately $1,613,000. Semler Scientific makes up 1.0% of Accuvest Global Advisors’ holdings, making the stock its 27th largest position.

Other hedge funds also recently made changes to their positions in the company. Summit Securities Group LLC purchased a new stake in shares of Semler Scientific in the first quarter worth about $32,000. SBI Securities Co. Ltd. lifted its position in shares of Semler Scientific by 161.3% in the first quarter. SBI Securities Co. Ltd. now owns 959 shares of the company’s stock worth $35,000 after buying an additional 592 shares in the last quarter. Corebridge Financial Inc. lifted its position in shares of Semler Scientific by 39.7% in the first quarter. Corebridge Financial Inc. now owns 3,298 shares of the company’s stock worth $119,000 after buying an additional 938 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Semler Scientific by 47.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company’s stock worth $144,000 after buying an additional 1,269 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its position in shares of Semler Scientific by 37.2% in the first quarter. MetLife Investment Management LLC now owns 4,134 shares of the company’s stock worth $150,000 after buying an additional 1,120 shares in the last quarter. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Semler Scientific in a research report on Wednesday, October 8th. Maxim Group decreased their target price on Semler Scientific from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Friday, September 19th. Benchmark decreased their target price on Semler Scientific from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Tuesday, September 23rd. Finally, Cantor Fitzgerald reduced their price objective on Semler Scientific from $61.00 to $60.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $74.25.

Semler Scientific Trading Up 7.5%

Shares of NASDAQ SMLR opened at $26.46 on Friday. The business’s 50 day moving average is $28.18 and its two-hundred day moving average is $33.73. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.60 and a quick ratio of 0.58. Semler Scientific Inc. has a 1-year low of $21.84 and a 1-year high of $81.56. The stock has a market capitalization of $400.60 million, a P/E ratio of 10.89 and a beta of 1.41.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings data on Monday, August 4th. The company reported $5.04 earnings per share for the quarter, topping the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The company had revenue of $8.22 million for the quarter, compared to analysts’ expectations of $8.10 million.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.